Mark Stein, MD, explores managing mHSPC through PSMA PET imaging, tumor burden assessment, and AMPLITUDE trial data while considering clinical context. The widespread adoption of PSMA PET imaging has ...
From caregiving needs to everyday convenience, real-world constraints make it difficult for some people to move away from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results